Publication | Open Access
β-Amyloid in CSF
78
Citations
20
References
2016
Year
Decreased levels of CSF Aβ<sub>40</sub> and Aβ<sub>42</sub> occur before HCHWA-D mutation carriers develop clinical symptoms, implicating vascular deposition of both Aβ species as early steps in cerebral amyloid angiopathy pathogenesis. CSF Aβ<sub>40</sub> and Aβ<sub>42</sub> may serve as preclinical biomarkers of cerebral amyloid angiopathy pathology.
| Year | Citations | |
|---|---|---|
Page 1
Page 1